ArticleBMC infectious diseases2026
High burden of Candida blankii (syn.Tardiomyces blankii) bloodstream infections among neonates in an intensive care unit in Bangladesh.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive fungal infections (IFIs) remain underrecognized in low- and middle-income countries due to limited surveillance. This study aims to report the burden of Candida blankii infections detected through ongoing surveillance in the Neonatal Intensive Care Unit (NICU) of a tertiary hospital in Dhaka, Bangladesh. Since August 2022, IFI surveillance in a NICU in Bangladesh enrolled neonates with sepsis who met predefined clinical criteria. Blood samples were collected and processed using the BACT/ALERT 3D system, and fungal isolates were identified with automated identification system. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using E-strip gradient diffusion. Whole-genome sequencing of nine representative C. blankii isolates, initially identified by VITEK MS, confirmed species identification by demonstrating 94% to 99% average nucleotide identity with reference sequences in the NCBI GenBank database. A total of 411 neonates were enrolled, with a mean age of 16 (± 7) days; 39% were male. More than half (225/411, 55%) had positive fungal blood cultures, among which C. blankii was the most common species (126/225, 31%). The isolates showed high MICs to fluconazole and voriconazole but lower MIC values against amphotericin B (AMP) and echinocandins. In-hospital mortality among C. blankii cases was significantly higher than in infections caused by other fungi. Findings indicate a substantial burden of C. blankii in the NICU and underscore the need for improved diagnostics, targeted treatment strategies, and strengthened infection control in resource-limited neonatal settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.